Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Cantor Fitzgerald
US Department of Justice
Deloitte
Federal Trade Commission
Colorcon
Express Scripts
Accenture

Generated: December 10, 2018

DrugPatentWatch Database Preview

Litigation Details for LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION (D.N.J. 2012)

« Back to Dashboard

LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION (D.N.J. 2012)

Docket ➤ Sign Up Date Filed 2012-02-17
Court District Court, D. New Jersey Date Terminated 2012-12-06
Cause 15:1 Antitrust Litigation Assigned To William H. Walls
Jury Demand Plaintiff Referred To Magistrate Judge Cathy L. Wald
Parties FEDERAL TRADE COMMISSION; GLAXOSMITHKLINE LLC; KING DRUG COMPANY OF FLORENCE, INC.; LOUISIANA WHOLESALE DRUG CO., INC.; MEIJER DISTRIBUTION, INC.; MEIJER INC.; PHV DEVORA W. ALLON; ROCHESTER DRUG CO-OPERATIVE, INC.; SMITHKLINE BEECHAM CORPORATION; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS; TEVA PHARMACEUTICALS USA, INC.
Patents 4,602,017; 5,698,226
Attorneys ALLYN ZISSEL LITE; ELENA K. CHAN; EVAN WAINHOUSE DAVIS; JAMES E. CECCHI; JOSEPH ALDO FISCHETTI; KIMBERLY MARION HENNINGS; LINDSAY DOBRZYNSKI BREEDLOVE; LINDSEY H. TAYLOR; MATTHEW F. GATELY; MELISSA J HATCH; MICHAEL E. PATUNAS; MIGUEL A. POZO; PETER S. PEARLMAN; RYAN JOHN COOPER; TIMOTHY JOHN SLATTERY; TIMOTHY STEPHEN JENKINS
Firms Federal Trade Commission; Lowenstein Sandler; Pashman Stein
Link to Docket External link to docket
Small Molecule Drugs cited in LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-02-17 1 primary exclusivity stemmed from U.S. Patent No. 4,602,017 (“the ‘017 patent”) which GSK listed in the FDA …017 patent, and these cases were subsequently consolidated (the “Patent Litigation”). The Patent Litigation…Lamictal Tablets. The ‘017 patent, along with another patent (U.S. Patent No. 5,698,226), was listed…infringed patent. No relevant regulatory exclusivities extended the life of the ‘017 patent itself per…the ‘017 patent. Thus, even though Teva had already succeeded in invalidating the ‘017 patent’s primary External link to document
2014-01-24 128 lamotrigine, covered by U.S. Patent No. 4,602,017 (“the ‘017 patent”). Id. ¶ 11. GSK’s patent for lamotrigine…a “quick look”: if a patent holder makes a reverse payment to a generic patent challenger, that payment…validity of the patent; and parties may well find ways to settle patent disputes without…compensates the patent challenger for “other services . . . such as distributing the patented item or helping…skeptically at patent settlements than did courts applying the “scope of the patent” test and there External link to document
2016-09-26 188 Exhibit A 241” OR “20-764”) “4,602,017” OR “017 patent” OR “5,698,226” OR “226 patent” “2:02-cv-03779” OR…SmithKline*) AND Teva AND (settl* OR licens* OR patent* OR infring* OR agree* OR (hatch w/2 waxman)…SmithKline*) AND Teva AND (settl* OR licens* OR patent* OR infring* OR agree* OR (hatch w/2 waxman) External link to document
2017-10-18 285 : # 1 Joint Stipulation Regarding U.S. Patent Number 5,698,226)(PEARLMAN, PETER) (Entered: 10/18/2017) External link to document
2017-10-19 289 JOINT STIPULATION AND ORDER REGARDINGU.S. PATENT NO. 5,698,226. Signed by Magistrate Judge Cathy L. Waldor External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Moodys
QuintilesIMS
Dow
Cantor Fitzgerald
Fish and Richardson
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.